Plain-English translation of NCT07615712 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Psoriasis research guide →This is an observational study that follows people with moderate to severe psoriasis who are starting a new advanced therapy for the first time. Researchers will collect information about your skin, how you're feeling, and your overall wellness at three time points: 2 weeks, 4 weeks, and 16 weeks after you begin the medication. The goal is to understand how well the treatment works and how it affects your daily life.
Dermatologists want to learn how new psoriasis medications perform in real-world settings and how they impact patients' lives beyond just skin appearance. This study will help doctors make better treatment decisions for people with moderate to severe psoriasis.
You likely qualify if…
You likely don't qualify if…
You'll visit your dermatologist three times over 16 weeks after starting the new medication. At each visit, your doctor will assess your skin using a standard rating scale, and you'll complete questionnaires about your symptoms and quality of life. Researchers will also collect information about your medical history, current medications, and how the treatment is working for you. The study is observational, meaning you're not randomly assigned to different groups—you're simply being followed as you receive your regular care.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
United States